Depleting glioblastoma cells of very long-chain acyl-CoA synthetase 3 (ACSVL3) produces metabolic alterations in non-lipid pathways
E. A. Kolar, X. Shi, E. M. Clay, Y. Liu, S. Xia, C. Zhang, A. Le, P. A. Watkins
This study shows that knocking out ACSVL3 in glioblastoma cells reduces their malignant traits by altering non-lipid metabolic pathways, including glucose and energy metabolism.
bioRxiv · Sep 18, 2023 · PreprintBiochemistry